Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment

Trastuzumab, a humanized monoclonal antibody derived from recombinant DNA, is used in patients with breast cancer with HER2 gene amplification. The survival benefit from trastuzumab has been well established in patients with early and metastatic breast cancer who had over expression of HER2. We repo...

Full description

Bibliographic Details
Main Authors: Zhou Qiong, Dong Jie, Jiang Xiaodong, Pan Yueyin, Han Xinghua
Format: Article
Language:English
Published: De Gruyter 2020-07-01
Series:Open Medicine
Subjects:
Online Access:https://doi.org/10.1515/med-2020-0201